316 related articles for article (PubMed ID: 7514677)
1. Primary pulmonary cytotoxic T lymphocytes induced by immunization with a vaccinia virus recombinant expressing influenza A virus nucleoprotein peptide do not protect mice against challenge.
Lawson CM; Bennink JR; Restifo NP; Yewdell JW; Murphy BR
J Virol; 1994 Jun; 68(6):3505-11. PubMed ID: 7514677
[TBL] [Abstract][Full Text] [Related]
2. Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses.
Altstein AD; Gitelman AK; Smirnov YA; Piskareva LM; Zakharova LG; Pashvykina GV; Shmarov MM; Zhirnov OP; Varich NP; Ilyinskii PO; Shneider AM
Arch Virol; 2006 May; 151(5):921-31. PubMed ID: 16292596
[TBL] [Abstract][Full Text] [Related]
3. Differential processing and presentation of the H-2D(b)-restricted epitope from two different strains of influenza virus nucleoprotein.
Potter P; Tourdot S; Blanchard T; Smith GL; Gould KG
J Gen Virol; 2001 May; 82(Pt 5):1069-1074. PubMed ID: 11297681
[TBL] [Abstract][Full Text] [Related]
4. Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge.
Fu TM; Guan L; Friedman A; Schofield TL; Ulmer JB; Liu MA; Donnelly JJ
J Immunol; 1999 Apr; 162(7):4163-70. PubMed ID: 10201942
[TBL] [Abstract][Full Text] [Related]
5. Effects of influenza virus-specific cytotoxic T-lymphocyte responses induced by a synthetic nucleoprotein peptide on the survival of mice challenged with a lethal dose of virus.
Sastry KJ; Bender BS; Bell W; Small PA; Arlinghaus RB
Vaccine; 1994 Nov; 12(14):1281-7. PubMed ID: 7856292
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the contribution of CTL epitopes in the immunobiology of morbillivirus infection.
Beauverger P; Cardoso AI; Daviet L; Buckland R; Wild TF
Virology; 1996 May; 219(1):133-9. PubMed ID: 8623522
[TBL] [Abstract][Full Text] [Related]
7. Intranasal administration of a synthetic peptide vaccine encapsulated in liposome together with an anti-CD40 antibody induces protective immunity against influenza A virus in mice.
Ninomiya A; Ogasawara K; Kajino K; Takada A; Kida H
Vaccine; 2002 Aug; 20(25-26):3123-9. PubMed ID: 12163263
[TBL] [Abstract][Full Text] [Related]
8. Naked RNA immunization with replicons derived from poliovirus and Semliki Forest virus genomes for the generation of a cytotoxic T cell response against the influenza A virus nucleoprotein.
Vignuzzi M; Gerbaud S; van der Werf S; Escriou N
J Gen Virol; 2001 Jul; 82(Pt 7):1737-1747. PubMed ID: 11413386
[TBL] [Abstract][Full Text] [Related]
9. Influenza basic polymerase 2 peptides are recognized by influenza nucleoprotein-specific cytotoxic T lymphocytes.
Anderson RW; Bennink JR; Yewdell JW; Maloy WL; Coligan JE
Mol Immunol; 1992 Sep; 29(9):1089-96. PubMed ID: 1495499
[TBL] [Abstract][Full Text] [Related]
10. Influenza-specific immunity induced by recombinant Listeria monocytogenes vaccines.
Ikonomidis G; Portnoy DA; Gerhard W; Paterson Y
Vaccine; 1997 Mar; 15(4):433-40. PubMed ID: 9141215
[TBL] [Abstract][Full Text] [Related]
11. Induction of cytotoxic T-cell responses by gene gun DNA vaccination with minigenes encoding influenza A virus HA and NP CTL-epitopes.
Fomsgaard A; Nielsen HV; Kirkby N; Bryder K; Corbet S; Nielsen C; Hinkula J; Buus S
Vaccine; 1999 Nov; 18(7-8):681-91. PubMed ID: 10547428
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of influenza haemagglutinin and nucleoprotein as protective antigens against influenza virus infection in mice.
Andrew ME; Coupar BE
Scand J Immunol; 1988 Jul; 28(1):81-5. PubMed ID: 2456608
[TBL] [Abstract][Full Text] [Related]
13. Homotypic and heterotypic protection against influenza virus infection in mice by recombinant vaccinia virus expressing the haemagglutinin or nucleoprotein of influenza virus.
Endo A; Itamura S; Iinuma H; Funahashi S; Shida H; Koide F; Nerome K; Oya A
J Gen Virol; 1991 Mar; 72 ( Pt 3)():699-703. PubMed ID: 2005435
[TBL] [Abstract][Full Text] [Related]
14. Lung homing CTLs and their proliferation ability are important correlates of vaccine protection against influenza.
Lin J; Somanathan S; Roy S; Calcedo R; Wilson JM
Vaccine; 2010 Aug; 28(35):5669-75. PubMed ID: 20600493
[TBL] [Abstract][Full Text] [Related]
15. Vaccination with DNA encoding internal proteins of influenza virus does not require CD8(+) cytotoxic T lymphocytes: either CD4(+) or CD8(+) T cells can promote survival and recovery after challenge.
Epstein SL; Stack A; Misplon JA; Lo CY; Mostowski H; Bennink J; Subbarao K
Int Immunol; 2000 Jan; 12(1):91-101. PubMed ID: 10607754
[TBL] [Abstract][Full Text] [Related]
16. Recognition of influenza A virus nucleoprotein by human cytotoxic T lymphocytes.
McMichael AJ; Michie CA; Gotch FM; Smith GL; Moss B
J Gen Virol; 1986 Apr; 67 ( Pt 4)():719-26. PubMed ID: 3485697
[TBL] [Abstract][Full Text] [Related]
17. Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization.
Fu TM; Friedman A; Ulmer JB; Liu MA; Donnelly JJ
J Virol; 1997 Apr; 71(4):2715-21. PubMed ID: 9060624
[TBL] [Abstract][Full Text] [Related]
18. Improving Cross-Protection against Influenza Virus Using Recombinant Vaccinia Vaccine Expressing NP and M2 Ectodomain Tandem Repeats.
Wang W; Huang B; Wang X; Tan W; Ruan L
Virol Sin; 2019 Oct; 34(5):583-591. PubMed ID: 31240620
[TBL] [Abstract][Full Text] [Related]
19. Immunization of mice with vaccinia virus-M2 recombinant induces epitope-specific and cross-reactive Kd-restricted CD8+ cytotoxic T cells.
Kulkarni AB; Morse HC; Bennink JR; Yewdell JW; Murphy BR
J Virol; 1993 Jul; 67(7):4086-92. PubMed ID: 7685408
[TBL] [Abstract][Full Text] [Related]
20. Heterologous protection against influenza by injection of DNA encoding a viral protein.
Ulmer JB; Donnelly JJ; Parker SE; Rhodes GH; Felgner PL; Dwarki VJ; Gromkowski SH; Deck RR; DeWitt CM; Friedman A
Science; 1993 Mar; 259(5102):1745-9. PubMed ID: 8456302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
